دورية أكاديمية
Front-line fludarabine-cyclophosphamide-rituximab (FCR) in 110 patients with chronic lymphocytic leukaemia (CLL): real-life experience with long-term outcomes, toxicities and responses to second-line therapies
| العنوان: | Front-line fludarabine-cyclophosphamide-rituximab (FCR) in 110 patients with chronic lymphocytic leukaemia (CLL): real-life experience with long-term outcomes, toxicities and responses to second-line therapies |
|---|---|
| المؤلفون: | Oliveira, Ana C.Aff1, IDs12185022034885_cor1, Roncero, Josep Maria, Ferrá, Christelle, Do Nascimento, Janilson, Rodriguez-Luaces, Marta, Encuentra, Maite, Domingo-Domenech, Eva, López, Patricia, Gallardo, David, Ribera, Josep Maria, Sarrá, Josep, Sureda, Anna, González-Barca, Eva |
| المصدر: | International Journal of Hematology. 117(3):388-397 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 09255710 18653774 |
|---|---|
| DOI: | 10.1007/s12185-022-03488-5 |